Current issues of the diagnosis and treatment of osteoporosis
An interview with Prof. Camil Castello Branco (University of Barcelona, Spain), the Chairman of the Council of Affiliated Menopause Societies of the International Menopause Society, and Prof. Svetlana S. Rodionova, the Head of the Center of Osteoporosis (N.N. Priorov Central Institute of Traumatology and Orthopedics, Moscow, Russia).

Interdisciplinary discussion of osteoporosis with the participation of gynecologist endocrinologist and traumatologist provided clinicians with relevant information on the prevention and treatment of this disorder. The role of calcium in osteoporosis treatment was highlighted. Recommended daily amount of calcium is 1-1.2 g. Intake of this amount of calcium in osteoporosis is required since the therapy is ineffective in calcium deficiency. Calcium supplement choice in different clinical conditions and specificity of fixed-dose combination (of calcium and vitamin D) prescription are discussed. Special attention is given to ossein-hydroxyapatite complex (OHC) and its advantages in terms of efficacy and safety, ease of use and dose selection (according to European study results). Thus, OHC does not provoke flatulence or dyspepsia. OHC dose can be adjusted for calcium intake with food. Early markers of osteoporosis in postmenopausal women, individual treatment regimens, and specificity of osteotropic pharmacotherapy in high risk of delayed consolidation are described.

Keywords: ossein-hydroxyapatite compound, calcium supplements, osteoporosis, vitamin D, menopause, densitometry, consolidation.

For citation: Current issues of the diagnosis and treatment of osteoporosis. An interview with C.C. Branco and S.S. Rodionova // RMJ. Rheumatology. 2016. № 2. P. –70.